Zobrazeno 1 - 10
of 95
pro vyhledávání: '"lncrna casc2"'
Autor:
Shymaa E. Ayoub, Olfat G. Shaker, Mohamed Masoud, Essam A. Hassan, Eman M. Ezzat, Mona I. Ahmed, Randa I. Ahmed, Amal A. Ibrahim Amin, Fadwa Abd El Reheem, Abeer A. Khalefa, Rania H. Mahmoud
Publikováno v:
Human Genomics, Vol 18, Iss 1, Pp 1-11 (2024)
Abstract Infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes coronavirus disease 2019 (COVID-19) has a high incidence of spread. On January 30, 2020, the World Health Organization proclaimed a public health emergency
Externí odkaz:
https://doaj.org/article/e19083781f0a4020bda10448b3d30e5f
Publikováno v:
Cell Journal, Vol 24, Iss 11, Pp 665-672 (2022)
Objective: Reportedly, long non-coding RNA (lncRNA) cancer susceptibility candidate 2 (CASC2) is involved inregulating colorectal cancer (CRC) progression. However, the function and detailed downstream mechanism of CASC2in CRC progression are not ful
Externí odkaz:
https://doaj.org/article/4db6e1fc0e6d4c7483641ba4a6203876
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of Asthma and Allergy, Vol Volume 15, Pp 197-207 (2022)
Yane Yang,1 Zhihong Sun,1 Tingting Ren,1 Wei Lei2 1Department of Pediatrics, The Second Affiliated Hospital of Xi‘an Medical University, Xi’an, Shaanxi, People’s Republic of China; 2Department of Pediatrics, Chang ‘an District Hospital, Xi‘
Externí odkaz:
https://doaj.org/article/ccbe09c653e84b98baf1b3d0ded11197
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 37, Iss 8, Pp 675-685 (2021)
Abstract Lung adenocarcinoma (LUAD) is the most common type of lung cancer. Currently, the survival rate of LUAD patients remains low due to heterogeneity and high invasiveness. The long non‐coding RNA (lncRNA) cancer susceptibility candidate 2 (CA
Externí odkaz:
https://doaj.org/article/9d30c72c80204b728522c29fc7fd24b8
Autor:
Jichun Sun, Hongbo Xu, Zhao Lei, Zhiqiang Li, Hongwei Zhu, Zhen Deng, Xiao Yu, Xiaoxin Jin, Zhi Yang
Publikováno v:
Frontiers in Oncology, Vol 11 (2022)
The immune cytokine tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) has been widely concerned as a tumor therapy because of its ability of selective triggering cancer cell apoptosis; nevertheless, hepatocellular carcinoma (HCC) exhibi
Externí odkaz:
https://doaj.org/article/92a41a1324ed4b839f5d17a5ba83f371
Autor:
Junsong Gong, Zujun Chen, Yu Chen, Huanran Lv, Haisong Lu, Fuxia Yan, Lihuan Li, Weili Zhang, Jia Shi
Publikováno v:
Respiratory Research, Vol 20, Iss 1, Pp 1-12 (2019)
Abstract Background In this study, we aimed to investigate whether and how lncRNA CASC2 was involved in hypoxia-induced pulmonary hypertension (PH)-related vascular remodeling. Methods The expression of lncRNAs or mRNAs was detected by qRT-PCR, and w
Externí odkaz:
https://doaj.org/article/734d17d7edff42659b951417ecc83046
Publikováno v:
Cell & Bioscience, Vol 8, Iss 1, Pp 1-11 (2018)
Abstract Background and objective Apoptosis of lung epithelial cell is implicated in the pathogenesis of acute lung injury (ALI). To study the protective effect and mechanism of cancer susceptibility candidate 2 (CASC2) on reducing lung epithelial ce
Externí odkaz:
https://doaj.org/article/c69a8941a57c4c21a7116fafc5b4998a
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Kaohsiung Journal of Medical Sciences, Vol 37, Iss 8, Pp 675-685 (2021)
Lung adenocarcinoma (LUAD) is the most common type of lung cancer. Currently, the survival rate of LUAD patients remains low due to heterogeneity and high invasiveness. The long non‐coding RNA (lncRNA) cancer susceptibility candidate 2 (CASC2) is r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::daae570c77481527eabe8738822b0f19
https://doi.org/10.1002/kjm2.12386
https://doi.org/10.1002/kjm2.12386